Healthcare (Prescription Drugs)

in committee · Washington · Senate Jan 12, 2026

SB 5326: Accessing an emergency supply of insulin.

SB 5326 creates a Washington State program to provide one emergency 30-day insulin supply per year for $10 out-of-pocket to eligible residents. It directly affects Washington residents who lack insurance coverage that already limits insulin costs to $35 or less per 30-day supply, have a valid prescription, and have less than a seven-day supply available. The program uses electronic vouchers redeemable at contracted pharmacies, with pharmacies submitting claims for reimbursement from the state's prescription drug consortium. The consortium then invoices insulin manufacturers for reimbursement within 30 days, with fines for nonpayment. This is a direct policy change to improve short-term insulin access for uninsured or underinsured Washington residents.

Topics ✓ Budget & TaxesSupports Budget & TaxesFunds essential insulin program via state budget with $10 out-of-pocket access, directly allocating public funds for healthcare needs.90% confidence ✓ HealthcareSupports HealthcareProvides $10 emergency insulin supply for uninsured residents lacking sufficient access, directly improving patient access to critical medication.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

signed · Washington · House May 17, 2025

HB 1382: Modernizing the all payers claim database.

HB 1382 modernizes Washington's statewide all-payer health care claims database, which collects medical and pharmacy claims data from various public and private health care payers. The bill updates reporting requirements and data disclosure standards for this database, aiming to improve transparency in health care costs and quality. It revises the process for selecting and overseeing the "lead organization" responsible for managing the database, allowing the Health Care Authority to either act as the lead or select one through a competitive process. Additionally, it specifies criteria for the lead organization and outlines entities, such as health plans or hospitals, that are ineligible for the role. The bill also details responsibilities for data vendors who collect and process the claims information to ensure data quality and security.

Topics ✓ HealthcareSupports HealthcareModernizes claims database to improve healthcare cost/quality transparency, directly advancing healthcare data accessibility and quality oversight per bill summary.95% confidence

Sub-Topics Prescription Drugs

in committee · Washington · Senate Jan 12, 2026

SB 5513: Expanding pharmacists' scope of practice to improve access to health care and the management of chronic diseases.

SB 5513 allows pharmacists in Washington to prescribe certain medications and devices to improve patient access to care, particularly for chronic diseases and behavioral health conditions. This expands pharmacists' current authority beyond dispensing drugs, enabling them to directly prescribe within their expertise. The bill directly affects pharmacists, patients in rural and underserved communities facing provider shortages, and healthcare systems seeking to address gaps in care. Key provisions include amending state laws to define pharmacists' new prescribing powers and align with their education and training, aiming to reduce barriers to treatment without requiring additional physician visits.

Topics ✓ HealthcareSupports HealthcareExpands pharmacists' prescribing authority to improve patient access, especially for chronic diseases in underserved areas.95% confidence

Sub-Topics Healthcare Workforce Medical Licensing Prescription Drugs

Track

in committee · Washington · House Jan 12, 2026

HB 1849: Expanding the drugs eligible for the unexpired prescription drug donation program.

HB 1849 expands Washington's unexpired prescription drug donation program by removing the requirement that donated drugs must have more than six months until expiration. This change allows pharmacies to accept a wider range of eligible drugs, directly affecting donors (like patients or healthcare providers), pharmacies participating in the program, and individuals receiving donated medications. Key provisions include updated safety checks by pharmacists, mandatory recall notifications for all parties involved, a prohibition on reselling donated drugs, and clarification that donated drugs cannot be reimbursed by health insurers. The bill aims to increase access to unused medications while maintaining safety standards through revised expiration timing and enhanced recall protocols.

Topics ✓ HealthcareSupports HealthcareExpands access to donated medications by removing expiration barriers, improving patient access to affordable drugs through expanded donation program eligibility.90% confidence

Sub-Topics Prescription Drugs

Track

in committee · Washington · House Jan 12, 2026

HB 1520: Expanding pharmacists' scope of practice to improve access to health care and the management of chronic diseases.

HB 1520 expands pharmacists' authority in Washington to prescribe certain medications and devices for managing chronic diseases, directly affecting patients in rural and underserved communities facing healthcare access challenges. The bill amends pharmacy law (RCW 18.64.011) to permit pharmacists to practice at the top of their training, including prescribing within defined scope for chronic conditions. Key provisions allow pharmacists to administer, dispense, and manage medications under specific protocols, improving care coordination without requiring physician oversight for these services. This change aims to address provider shortages by leveraging pharmacists' expertise to enhance patient outcomes in primary care settings.

Topics ✓ HealthcareSupports HealthcareBill explicitly expands pharmacists' prescribing authority for chronic disease management in underserved communities, directly improving healthcare access as stated in summary.95% confidence

Sub-Topics Healthcare Workforce Medical Licensing Prescription Drugs

Track

signed · Washington · House Apr 25, 2025

HB 1971: Increasing access to prescription hormone therapy.

HB 1971 requires health plans to provide reimbursement for a 12-month refill of covered prescription hormone therapy, obtained at one time, for their enrollees. This aims to increase access to these medications for patients of all ages. Starting January 1, 2026, health plans must comply, unless the enrollee requests a smaller supply, the provider instructs a smaller supply, or the therapy is a controlled substance. The 12-month supply applies to medications that can be safely stored at room temperature, while controlled substances must be covered for the maximum refill allowed by law. Prescription hormone therapy is defined as FDA-approved drugs that medically adjust hormone levels, excluding certain glucagon-like peptide-1 medications.

Topics ✓ HealthcareSupports HealthcareMandates 12-month coverage for hormone therapy, improving patient access to medications under insurance plans.90% confidence

Sub-Topics Prescription Drugs

in committee · Washington · House Jan 12, 2026

HB 1725: Increasing access to biosimilar medicines.

HB 1725 requires health plans in Washington to streamline access to biosimilar medicines (safe, effective, lower-cost alternatives to brand-name biologics) by mandating clear exception processes for coverage denials. It directly affects patients, doctors, and health insurance companies by requiring health plans to: (1) post plain-language exception rules online, (2) approve exceptions meeting specific medical criteria (like drug ineffectiveness or adverse reactions), and (3) follow strict timelines (1-3 business days) for urgent/non-urgent requests. The bill eliminates barriers by ensuring health plans must cover biosimilars when clinical evidence supports them, with automatic approval if deadlines are missed. This aims to reduce prescription drug costs without altering drug approval standards.

Topics ✓ HealthcareSupports HealthcareMandates health plans to streamline biosimilar access via clear exception processes, improving patient access to lower-cost alternatives and reducing coverage denials for medically necessary treatments.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

in committee · Washington · Senate Jan 12, 2026

SB 5019: Concerning prepacked medication distribution.

SB 5019 allows hospitals in Washington to distribute prepackaged emergency medications directly to patients being discharged from emergency departments when community or outpatient pharmacy services are unavailable within 15 miles or within a reasonable time. It specifically permits limited supplies (up to 48 hours) of medications like opioid overdose reversal drugs, HIV postexposure prophylaxis, antibiotics, and other prepackaged drugs, with exceptions for longer durations when medically necessary. Hospitals must establish strict protocols including pharmacist oversight, staff training, secure storage, and patient counseling before distribution. The bill does not apply to routine medication dispensing but ensures continuity of care for urgent needs during pharmacy access gaps.

Topics ✓ HealthcareSupports HealthcareEnables direct medication access during pharmacy shortages, improving emergency care continuity without restricting services.95% confidence

Sub-Topics Prescription Drugs Substance Abuse

Track